The Chinese EV Maker, ExPong, Is Planning to Shave Its Cost Dramatically by the End of 2024

Merck will buy Prometheus Biosciences for about $10.8 billion. ExPong plans to cut 25% off the cost of its powertrain and save 50% on intelligent driving features by end of next year. The Chinese EV maker is set to introduce a new mid-sized SUV at the Shanghai Auto Show tomorrow.